A Single Arm Phase II Study to Evaluate Treatment With Gevokizumab in Patients With Stage II/III Colon Cancer Who Are ctDNA-positive After Curative Surgery and Adjuvant Chemotherapy
PHASE2
This study will look at the recurrence-free survival of microsatellite-stab...
Status
Withdrawn
Location
UF Health Davis Cancer Pavilion and Shands Med Plaza
A Multicenter Randomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors.
NA
This is a multicenter, open-label, randomized (1:1) trial designed to evalu...